Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bicycle Therapeutics (BCYC) Construction in Progress (2022 - 2023)

Bicycle Therapeutics' Construction in Progress history spans 2 years, with the latest figure at $400000.0 for Q2 2023.

  • For Q2 2023, Construction in Progress changed N/A year-over-year to $400000.0; the TTM value through Jun 2023 reached $400000.0, changed N/A, while the annual FY2022 figure was $2.3 million, N/A changed from the prior year.
  • Construction in Progress reached $400000.0 in Q2 2023 per BCYC's latest filing, down from $2.3 million in the prior quarter.
  • In the past five years, Construction in Progress ranged from a high of $2.3 million in Q4 2022 to a low of $400000.0 in Q2 2023.